Both in Biotechnology
4D Molecular Therapeutics vs Solid Biosciences
Over the past year FDMT returned +6.5% and SLDB returned +20.8%; their daily moves had a correlation of 0.53.
FDMT +6.5% SLDB +20.8%Growth of $1, one year, split-adjusted
| Metric | FDMT | SLDB |
|---|---|---|
| Price | $11.95 | $6.28 |
| Market cap | $660.2M | $673.4M |
| Today | +5.10% | +4.67% |
| 1 month | −7.5% | −11.0% |
| 6 months | +23.1% | −9.0% |
| Year to date | +59.3% | +11.3% |
| 1 year | +3.9% | +16.5% |
| Revenue growth (YoY) | +25106.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −1929.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.2× | — |
| Net cash | $341.7M | $377.7M |
| Dividend yield | — | — |
| Volatility (60d) | 76.2% | 68.3% |
| Short % of float | 21.6% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).